Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on... The Role of the NSABP in Breast Cancer Research Past, and Warnings for the Future—with NORMAN WOLMARK, MD

  Sarah DiGiulio

• Free

  CML: First-line Therapy with Dasatinib + Pegylated Interferon Induces Deep Molecular Responses

  Mark L. Fuerst

• Free

  Dana-Farber Program Seeks to Improve Conversations with Patients with Serious Illness

  Lola Butcher

• Free

  Dose Optimization of Nilotinib Boosts Molecular Response in CML

  Markl L. Fuerst

• Free

  FDA Approves Keytruda for Melanoma
• Free

  FDA Approves Opdivo for Advanced Renal Cell Carcinoma
• Free

  FDA Breakthrough Therapy Status to Third-Generation TKI, BI 1482694, for NSCLC
• Free

  FDA's Fast Track Status to Brilacidin-OM for Oral Mucositis
• Free

  How We Treat Patients with Myelofibrosis

  Prithviraj Bose MD,Srdan Verstovsek MD, PhD

• Free

  OT Editorial Board's Predictions for the Future
• Free

  Poetry by Cancer Caregivers

  Lisa Danko NP

• Free

  View from the Other Side of the Stethoscope: Just a Practitioner

  Wendy S. Harpham MD

• Free

  VOICES: Despite Advances, Ovarian Cancer Remains Challenging
• Buy

  ASH PLENARY STUDY: Targeted Agent Improves Survival in AML Patients with FLT3 Mutations

  Mark L. Fuerst

• Buy

  Best Leukemia Abstracts from ASH 2015

  Tapan M. Kadia MD

• Buy

  Best Lung Cancer Research, 2015

  Tom Stinchcombe MD

• Buy

  Best Myeloma Abstracts from ASH 2015

  Ravi Vij MD, MBA

• Buy

  Case Study: Complex Pain Management

  Jeannine M. Brant PhD, APRN, AOCN, FAAN

• Buy

  EGFR Amplification in Lung Cancer: Time for Thawing the Frozen FISH?

  Federico Cappuzzo MD, PhD,Fred R. Hirsch MD, PhD,Paul A. Bunn MD,Wilbur A. Franklin MD,Marileila Varella-Garcia PhD

• Buy

  How to Best Use Immunotherapy Combinations for Lung Cancer

  Mark L. Fuerst

• Buy

  New Use for Rituximab: Addition to Chemotherapy in Adult ALL

  Mark L. Fuerst

• Buy

  Online Patient Symptom Reporting Shown to Improve Outcomes

  Kurt Samson

• Buy

  POINT-COUNTERPOINT: Does Sentinel Lymph Node Biopsy Extend Survival in Melanoma?

  Mark L. Fuerst

• Buy

  Study: Community Oncologists Reluctant to Follow Guidelines for Thrombosis in Cancer Patients

  Markl L. Fuerst

• Buy

  Targeted Therapies Show Impressive Results in Relapsed/Refractory CLL

  Mark L. Fuerst

• Buy

  Word to Oncologists: Do More to Report and Prevent Falls in Older Patients

  Kurt Samson